1. Home
  2. SSD vs PTGX Comparison

SSD vs PTGX Comparison

Compare SSD & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Simpson Manufacturing Company Inc.

SSD

Simpson Manufacturing Company Inc.

N/A

Current Price

$202.21

Market Cap

8.2B

ML Signal

N/A

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

N/A

Current Price

$135.63

Market Cap

9.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SSD
PTGX
Founded
1956
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
9.3B
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
SSD
PTGX
Price
$202.21
$135.63
Analyst Decision
Buy
Strong Buy
Analyst Count
5
14
Target Price
★ $213.60
$182.36
AVG Volume (30 Days)
298.8K
★ 595.7K
Earning Date
10-26-2026
11-05-2026
Dividend Yield
★ 0.59%
N/A
EPS Growth
★ 8.42
N/A
EPS
★ 7.90
5.43
Revenue
★ $2,332,808,000.00
N/A
Revenue This Year
$4.05
$1,132.66
Revenue Next Year
$2.88
N/A
P/E Ratio
$25.82
★ $25.02
Revenue Growth
★ 4.51
N/A
52 Week Low
$156.32
$77.00
52 Week High
$213.49
$160.81

Technical Indicators

Market Signals
Indicator
SSD
PTGX
Relative Strength Index (RSI) 63.01 44.76
Support Level $167.63 $135.10
Resistance Level $211.60 $143.61
Average True Range (ATR) 5.87 5.48
MACD 1.22 -0.50
Stochastic Oscillator 77.11 40.97

Price Performance

Historical Comparison
SSD
PTGX

About SSD Simpson Manufacturing Company Inc.

Simpson Manufacturing Co Inc designs, manufactures, and markets systems and products to make buildings and structures safe and secure. It produces wood construction products, including connectors, truss plates, fastening systems, fasteners, and shearwalls, as well as concrete construction products such as adhesives, specialty chemicals, mechanical anchors, powder actuated tools, and fiber reinforcing materials. The company serves residential, industrial, commercial, and infrastructure construction, remodeling, and do-it-yourself markets, operating exclusively in the building products industry. It has three regional segments: North America, Europe, and Asia/Pacific. The majority of its revenue comes from wood products.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: